WebThe chart on this page features a breakdown of the total annual pay for Cynthia Collins … WebApr 13, 2024 · CAMBRIDGE, Mass., April 13, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical stage genome editing company, today announced the appointment of current Independent Director Emma Reeve as Chair of the Board, effective at the Company’s next annual stockholder meeting, currently scheduled for June 1.
Editas Medicine Appoints Cynthia Collins as President and Chief ...
WebMar 5, 2024 · A first patient has been treated in a trial of an Allergan and Editas drug based on CRISPR/Cas9, a technology that allows genes to be manipulated inside the body. The two companies claim AGN ... WebJul 26, 2024 · Ms. Collins most recently served as the CEO of Editas Medicine, and prior to that served as the CEO of Human Longevity, Inc.; the CEO/GM of the Cell Therapy and Lab Business of General... high flow therapie dräger
Cynthia Collins
WebAbout Cynthia Collins. Member of the Board @ Triumvira Immunologics Austin, Texas and Toronto, CanadaBoard Member @ Editas Medicine Boston, MassachusettsCEO/GM, In Vitro Diagnostics, Research & Applied Markets, and Cell Therapy @ GE Healthcare From October 2013 to December 2016 (3 years 3 months) Boston, MAChief Executive Officer … WebCynthia Collins CAMBRIDGE, Mass., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Editas … WebHe joined Editas Medicine in June 2024 and is responsible for leading Editas Medicine’s regulatory affairs strategy and activities related to its drug development programs. Chi brings to Editas more than 20 years of … high flow therapie definition